SCHEMBL8970546

SCHEMBL8970546

COc1cccc2c1CC(CN(CCCNS(=O)(=O)c1ccc(F)cc1)Cc1ccccc1)CC2

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.43
HTR1A P08908 2/20 0.43
DRD4 P21917 1/20 0.43
ADRA1D P25100 1/20 0.43
ADRA1A P35348 1/20 0.43
ADRA1B P35368 1/20 0.43
DRD3 P35462 1/20 0.43
SIGMAR1 Q99720 2/20 0.43
TMEM97 Q5BJF2 1/20 0.43
CHRM2 P08172 1/20 0.42
CHRM1 P11229 1/20 0.42
CHRM3 P20309 1/20 0.42
TAAR1 Q96RJ0 1/20 0.40
ALDH1A1 P00352 1/20 0.39
USP2 O75604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8969014 0.86 CHRM2 (0.43) DRD2HTR1ASIGMAR1CHRM2CHRM1
SCHEMBL8970393 0.86 TAS2R14 (0.45) DRD2HTR1ASIGMAR1CHRM2CHRM1
SCHEMBL8969041 0.80 CHRM2 (0.51) DRD2HTR1ADRD4ADRA1DADRA1A
SCHEMBL8970549 0.80 MTNR1A (0.54) DRD2HTR1ADRD3SIGMAR1TMEM97
SCHEMBL8970649 0.79 BACE1 (0.47) DRD2HTR1ASIGMAR1CHRM2CHRM1
SCHEMBL8971881 0.78 CA1 (0.44) DRD2HTR1ADRD3SIGMAR1
SCHEMBL8969348 0.76 MTNR1A (0.46) DRD2HTR1ASIGMAR1CHRM2CHRM1
SCHEMBL9533770 0.75 DRD2 (0.53) DRD2HTR1ADRD4ADRA1DADRA1A
SCHEMBL8996694 0.75 MTNR1A (0.46) DRD2HTR1ADRD3SIGMAR1CHRM2
Hydrochloric Acid SCHEMBL9243922 0.75 DRD2 (0.52) DRD2HTR1ADRD4ADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5585392-A TREATING OR PREVENTING STROKES BAYER AKTIENGESELLSCHAFT (DE) 1996-12-17 US disclosed
US-5506246-A Method for treating depression using substituted aminomethyltetralins and their heterocyclic analogues BAYER AKTIENGESELLSCHAFT (DE) 1996-04-09 US disclosed
EP-0352613-B1 Substituted amino methyl tetralines, and their heterocyclic analogous compounds BAYER AG (DE) 1994-04-20 EP disclosed
US-5300523-A Binding serotonin receptors, treating nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1994-04-05 US disclosed
US-5137901-A For binding 5-HT 1 receptors; treating central nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1992-08-11 US disclosed
EP-0352613-A2 Substituted amino methyl tetralines, and their heterocyclic analogous compounds BAYER AG (DE) 1990-01-31 EP disclosed